Key Segments:
By Form
-
Tablets
-
Granules
-
Powder
By Application
-
Swimming Pool and Spa Water Treatment
-
Agriculture and Aquaculture Water Treatment
-
Industrial and Municipal Water Treatment
-
Textile Bleaching
-
Others
Regional Coverage:
North America
-
US
-
Canada
Europe
-
Germany
-
France
-
UK
-
Italy
-
Spain
-
Poland
-
Russia
-
Rest of Europe
Asia Pacific
-
China
-
India
-
Japan
-
South Korea
-
Australia
-
ASEAN Countries
-
Rest of Asia Pacific
Middle East & Africa
-
UAE
-
Saudi Arabia
-
Qatar
-
South Africa
-
Rest of Middle East & Africa
Latin America
-
Brazil
-
Argentina
-
Mexico
-
Colombia
-
Rest of Latin America
Available Customization
With the given market data, SNS Insider offers customization as per the company’s specific needs. The following customization options are available for the report:
-
Detailed Volume Analysis
-
Criss-Cross segment analysis (e.g. Product X Application)
-
Competitive Product Benchmarking
-
Geographic Analysis
-
Additional countries in any of the regions
-
Customized Data Representation
-
Detailed analysis and profiling of additional market players
Frequently Asked Questions
The market includes OxyChem (Berkshire Hathaway), Ercros, Nissan Chemical Corporation, Heze Huayi Chemical, Juancheng Kangtai Chemical, Bio-Lab (KIK Consumer Products), Hebei Jiheng Chemical, Shikoku Kasei Holdings, Zhucheng Taisheng Chemical, Arxada, Clearon (Solenis), Nippon Soda, Nankai Chemical, Fluidra, Hebei Xingfei Chemical, Inner Mongolia Lantai Chemical, Shandong Daming, Taian Huatian Chemical, Acuro Organics and Shandong Taihe Water Treatment Technologies, among others.
The main opportunities lie in desalination chemical-dosing partnerships, aquaculture-focused water-treatment protocols, municipal infrastructure-renewal procurement and water-technology manufacturing localization in the Middle East.
The key growth factor is aging municipal water infrastructure requiring renewal, combined with expanding desalination investment and growing fish and shrimp farming operations adopting systematic water treatment.
By form, the Tablets segment dominated the market with approximately 48.60% share in 2025, supported by predictable dosing and lower handling risk relative to granular product.
Asia Pacific dominated the market with approximately 35.30% share in 2025, supported by concentrated chlor-alkali production capacity across China. Asia Pacific is also the fastest-growing region with a projected CAGR of approximately 6.90% from 2026 to 2035.
